000 | 01675 a2200505 4500 | ||
---|---|---|---|
005 | 20250513135307.0 | ||
264 | 0 | _c19980318 | |
008 | 199803s 0 0 eng d | ||
022 | _a0008-543X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRibas, A | |
245 | 0 | 0 |
_aCyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma. _h[electronic resource] |
260 |
_bCancer _cMar 1998 |
||
300 |
_a878-85 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntidotes _xadministration & dosage |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aBreast Neoplasms, Male _xdrug therapy |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGastrointestinal Diseases _xchemically induced |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfusions, Intravenous |
650 | 0 | 4 |
_aLeucovorin _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aTegafur _xadministration & dosage |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aAlbanell, J | |
700 | 1 | _aSolé-Calvo, L A | |
700 | 1 | _aGallardo, E | |
700 | 1 | _aBellmunt, J | |
700 | 1 | _aVera, R | |
700 | 1 | _aVidal, R | |
700 | 1 | _aCarulla, J | |
700 | 1 | _aBaselga, J | |
773 | 0 |
_tCancer _gvol. 82 _gno. 5 _gp. 878-85 |
|
999 |
_c9454750 _d9454750 |